ArticleGene therapy2026

CRISPR/Cas9-mediated gene correction of Wilson disease H1069Q point mutation in patient-specific induced pluripotent stem cells.

Viktoria Iwan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.